Navigation Links
New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Date:11/30/2009

including, without limitation, the potential failure of bis-platinums to prove effective in inhibiting or delaying tumor growth or to overcome cisplatin resistance or to be safe or effective in animals or humans, that CTI does not enter clinical trials for the bis-platinates in 2010, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.



Media Contact:                       Investors Contact:
Dan Eramian                          Ed Bell
T: 206.272.4343                      T: 206.272.4345
C: 206.854.1200                      Lindsey Jesch Logan
F: 206.272.4434                      T: 206.272.4347
E: deramian@ctiseattle.com           F: 206.272.4434
www.celltherapeutics.com/press_room  E: invest@ctiseattle.com
                                     www.celltherapeutics.com/investors



SOURCE Cell Therapeutics, Inc.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pragmedic Implements World-Class Healthcare Solution for Emaar Healthcare
2. Tetraphase Presents Study Results for Novel Classes of Antibiotics from its Breakthrough Synthetic Chemistry Platform at ICAAC 2009
3. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
4. Quantros ACE Helps East Jefferson General Hospital Achieve Best-in-Class Performance
5. BioNeutrals Ygiene(TM) Hospital Grade Achieves World Class Independent Test Results in Killing Life Threatening Spores/Organisms
6. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
7. CellGard ES NU-480 Class II Biological Safety Cabinet Now Available
8. NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza
9. UKs Institute of Cancer Research and Silicon Graphics Establish Long-Term Alliance to Design and Outfit World-Class Network Biology Lab
10. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
11. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... This research report “Biodegradable Plastics Market by ... Cellulose, PCL), by Application (Packaging, Fibers, Agriculture, Injection ... defines and segments the global biodegradable plastics market ... volume and value. , Browse 75 Market Data ... and in-depth TOC on “Biodegradable Plastics Market by ...
(Date:10/25/2014)... Great Barrington, MA (PRWEB) October 25, 2014 ... contamination control products, is pleased to announce the ... to achieve the highest level of contamination containment ... in ISO Class 3 and higher cleanroom environments, ... continuous filament polyester knit laundered wiper that continues ...
(Date:10/25/2014)... Investor-Edge has initiated coverage on ... ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), ... Pharmaceuticals Inc. (NASDAQ: PPHM ), and StemCells ... can be accessed at: http://investor-edge.com/register . ... on a positive note as the Dow Jones Industrial ...
(Date:10/22/2014)... , Oct. 22, 2014 Research ... the "Global DNA Diagnostics Market (Product types, ... Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ... 2020" report to their offering. ... (products, applications, techniques, end users and Geography) Global ...
Breaking Biology Technology:Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3
... Conn. , April 28 Goodwin Biotechnology Inc., a full ... development services company, jointly announced today their collaborative agreement to create ... services. , , , ... collaboration will enhance and strengthen the clinical development services integrating cDNA ...
... 28 The global biotechnology industry was able to ... financial performance in 2009, with the world,s established biotech centers ... gap between the "haves" and "have nots" in the industry ... companies in accessing the capital needed for R&D. These and ...
... ... of its Global Food, Agribusiness and Biofuels practice, presents findings today from a new ... and Agricultural Infrastructure" at the Land Conference 2010 organized by The World Bank in ... ...
Cached Biology Technology:Goodwin Biotechnology Inc. and Hyprocell LLC Announce Collaboration 2Goodwin Biotechnology Inc. and Hyprocell LLC Announce Collaboration 3Biotech Industry Showing Resilience Despite Challenging Conditions 2Biotech Industry Showing Resilience Despite Challenging Conditions 3Biotech Industry Showing Resilience Despite Challenging Conditions 4Biotech Industry Showing Resilience Despite Challenging Conditions 5Biotech Industry Showing Resilience Despite Challenging Conditions 6Biotech Industry Showing Resilience Despite Challenging Conditions 7Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 2Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 3Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 4
(Date:10/25/2014)... A recent report, "Genetic Testing Market Outlook 2018", provides ... testing market. A comprehensive introduction of gene-based tests, their ... On account of our analysis of the past and ... forecast for genetic testing has been drawn, according to ... CAGR of around 9% during 2013-2018. Our report ...
(Date:10/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended September 30, 2014. Revenue for the ... 40% compared to $4.3 million in the same quarter last ... $4.1 million compared to $1.0 million in the third quarter ... period was primarily due to: i) a $1.0 million increase ...
(Date:10/17/2014)... is critical and pertinent for practicing physicians and clinicians ... epidemic. The Journal, Disaster Medicine and Public Health ... and Public Health, to surround the public, medical professionals ... moment. , On October 17, the journal published ... primer was prepared by Dr. Eric Toner, internist and ...
Breaking Biology News(10 mins):Genetic Testing Market Outlook 2018 2Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7
... Groundbreaking research led by the U.S. Department of Energy ... time that the signatures of the genes alone in ... of the sampled environments. This study, published in the ... genome sequencing to accelerate advances in environmental sciences akin ...
... throughput microarray analyses result in many differentially expressed ... process of interest. In order to identify biological ... in which pairs of gene names and combinations ... , MEDLINE search strings for 15,621 known genes ...
... Joslin Diabetes Center have found genetic regions that, when defective, ... in a series of mis-steps that lead to type 1 ... journal Immunity, the researchers are now trying to hone in ... patients. , “The significance of this study is that we ...
Cached Biology News:Study reveals new technique for fingerprinting environmental samples 2Study reveals new technique for fingerprinting environmental samples 3Genetic defects give the immune system the green light to attack the pancreas 2Genetic defects give the immune system the green light to attack the pancreas 3
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... Mouse anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... assay dependent dilution. ICC: Use at an assay ... 5 - 10 ug/ml, this concentration is determined ... molecular weight: 40 kDa. Not tested in other ...
SHP-2 Antibody...
... Glycine Transporter 2, Neuronal (GLYT2). The ... from the central nervous system. The staining ... pattern described using in situ hybridization with ... has been described for glycinergic neurons. Preabsorption ...
Biology Products: